MY

Murtuza Yusufali Adenwala

Active Director Designated Partner DIN 10455103
DIN 10455103 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Murtuza Yusufali Adenwala

Data last updated:

Murtuza Yusufali Adenwala is a Designated Partner at Afiyat Revivecare Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10455103
Primary Designation Designated Partner
Industry Pharma
First Appointment 05 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Jan 20242024Active

Board colleagues of Murtuza Yusufali Adenwala

Directorship timeline

Open interactive timeline →
Afiyat Revivecare Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Murtuza Yusufali Adenwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murtuza Yusufali Adenwala

Murtuza Yusufali Adenwala currently holds 1 directorship: Afiyat Revivecare Pharmaceuticals Llp (Designated Partner, since 05 Jan 2024).

Murtuza Yusufali Adenwala was first appointed on 05 Jan 2024 as Designated Partner at Afiyat Revivecare Pharmaceuticals Llp.

The current boards of Murtuza Yusufali Adenwala's companies include Juzar Fazaleabbas Munsif (Afiyat Revivecare Pharmaceuticals Llp), Juzarbhai Sirajbhai Parekh (Afiyat Revivecare Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available